Opposing roles of the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated downregulation of tropomyosin

被引:59
作者
Shields, JM [1 ]
Mehta, H [1 ]
Pruitt, K [1 ]
Der, CJ [1 ]
机构
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA
关键词
D O I
10.1128/MCB.22.7.2304-2317.2002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We showed previously that activated Ras, but not Raf, causes transformation of RIE-1 epithelial cells, demonstrating the importance of Raf-independent pathways in mediating Ras transformation. To assess the mechanism by which Raf-independent effector signaling pathways contribute to Ras-mediated transformation, we recently utilized representational difference analysis to identify genes expressed in a deregulated fashion by activated Ras but not Rat. One gene identified in these analyses encodes for alpha-tropomyosin. Therefore, we evaluated the mechanism by which Ras causes the downregulation of tropomyosin expression. By using RIE-1 cells that harbor inducible expression of activated H-Ras(12V), we determined that the downregulation of tropomyosin expression correlated with the onset of morphological transformation. We found that the reversal of Ras transformation caused by inhibition of extracellular signal-regulated kinase activation corresponded to a restoration of tropomyosin expression. Inhibition of p38 activity in Raf-expressing RIE-1 cells caused both morphological transformation and loss of tropomyosin expression. Thus, a reduction in tropomyosin expression correlated strictly with morphological transformation of RIE-1 cells. However, forced overexpression of tropomyosin in Ras-transformed cells did not reverse morphological or growth transformation, a finding consistent with the possibility that multiple changes in gene expression contribute to Ras transformation. We also determined that tropomyosin expression was low in two human tumor cell lines, DLD-1 and HT1080, that harbor endogenous mutated alleles of ras, but high in transformation-impaired, derivative cell lines in which the mutant ras allele has been genetically deleted. Finally, treatment with azadeoxycytidine restored tropomyosin expression in Ras-transformed RIE-1, HT1080, and DLD-1 cells, suggesting a role for DNA methylation in downregulating tropomyosin expression.
引用
收藏
页码:2304 / 2317
页数:14
相关论文
共 72 条
[11]  
COOPER HL, 1987, CANCER RES, V47, P4493
[12]   THE SMALL GTP-BINDING PROTEINS RAC1 AND CDC42 REGULATE THE ACTIVITY OF THE JNK/SAPK SIGNALING PATHWAY [J].
COSO, OA ;
CHIARIELLO, M ;
YU, JC ;
TERAMOTO, H ;
CRESPO, P ;
XU, NG ;
MIKI, T ;
GUTKIND, JS .
CELL, 1995, 81 (07) :1137-1146
[13]   Role of the ras-MAPK signaling pathway in the DNA methyltransferase response to DNA hypomethylation [J].
Deng, C ;
Yang, J ;
Scott, J ;
Hanash, S ;
Richardson, BC .
BIOLOGICAL CHEMISTRY, 1998, 379 (8-9) :1113-1120
[14]  
GABBIANI G, 1976, AM J PATHOL, V83, P457
[15]   A Raf-independent epidermal growth factor receptor autocrine loop is necessary for Ras transformation of rat intestinal epithelial cells [J].
Gangarosa, LM ;
Sizemore, N ;
GravesDeal, R ;
Oldham, SM ;
Der, CJ ;
Coffey, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) :18926-18931
[16]   Forced expression of tropomyosin 2 or 3 in v-Ki-ras-transformed fibroblasts results in distinct phenotypic effects [J].
Gimona, M ;
Kazzaz, JA ;
Helfman, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (18) :9618-9623
[17]   Association of K-ras mutations with p16 methylation in human colon cancer [J].
Guan, RJ ;
Fu, YN ;
Holt, PR ;
Pardee, AB .
GASTROENTEROLOGY, 1999, 116 (05) :1063-1071
[18]   Rho GTPases and the actin cytoskeleton [J].
Hall, A .
SCIENCE, 1998, 279 (5350) :509-514
[19]   Role of substrates and products of PI3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav [J].
Han, JW ;
Luby-Phelps, K ;
Das, B ;
Shu, XD ;
Xia, Y ;
Mosteller, RD ;
Krishna, UM ;
Falck, JR ;
White, MA ;
Broek, D .
SCIENCE, 1998, 279 (5350) :558-560
[20]  
Hashimoto Y, 1996, CANCER RES, V56, P5266